20.11.2019
- The US Federal Trade Commission has approved Bristol-Myers Squibb’s $74 billion takeover of biotech Celgene by a vote of 3 to 2. The biggest merger in the history of the global...
13.09.2019
- Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...
17.04.2019
- Shareholders of Bristol Myers Squibb (BMS) have approved the company’s $74 billion acquisition of Celgene. At the special meeting on Apr. 12, altogether 75% of the shareholders...
08.04.2019
- The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious...
02.04.2019
- Activist investor Starboard Value has backed away from plans to torpedo the proposed $74 billion merger of Bristol-Myers Squibb with Celgene after independent proxy advisory firms...
01.03.2019
- Activist investor Starboard Value, which very recently bought a 1 million share in Bristol-Myers Squibb (BMS) and nominated five directors to the board, has now made public its...
18.02.2019
- Within a week, US biotech Celgene, which is in the process of being acquired by Bristol-Myers-Squibb (BMS), dodged a challenge to its patent for the blockbuster multiple myeloma...
05.02.2019
- The proposed $74 billion takeover of US biotech Celgene by compatriot BristolMyers Squibb (BMS), announced last month, may be looking somewhat shaky. Analysts and investors up to...
